The metastatic tumor antigen 1 (MTA1) is closely correlated to poor prognosis and frequent postoperative recurrence in patients with HCC, particularly in those with HBV-HCC [145,146,147]. The gene discussed is MTA1; the disease is hepatocellular carcinoma.